Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy - ScienceDirect
Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias | JACC: Clinical Electrophysiology
Tumor mutational burden and immunotherapy in gliomas: Trends in Cancer
High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy | SpringerLink
Pathogens | Free Full-Text | Comprehensive Overview of Toxoplasma gondii-Induced and Associated Diseases
The burden of cutaneous disease in solid organ transplant recipients of color - American Journal of Transplantation
Cancers | Free Full-Text | Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression
Patient-centred approaches for the management of unpleasant symptoms in kidney disease | Nature Reviews Nephrology
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect
Frontiers | Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms | Oncogenesis
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial - American Journal of Transplantation
Transplantology | Free Full-Text | Strategies to Improve Immune Suppression Post-Liver Transplantation: A Review
Targeted Therapy and Immunosuppression in the Tumor Microenvironment: Trends in Cancer
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation - ScienceDirect
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
Frontiers | Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
Cancer Risk Among Immunosuppressed Populations - NCI
Table 1 from Immunosuppressive therapy in lung transplantation: state of the art. | Semantic Scholar
Can immunosuppression be stopped after liver transplantation? - The Lancet Gastroenterology & Hepatology
Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
